Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04259762 · ClinicalTrials.gov registry record · NA

Enhancing Cancer Prevention and Control Pathways-Native Health Initiative

A NA study, sponsored by New Mexico Cancer Research Alliance.

Completed
Registry status
NA
Development phase
508
Enrollment target

NCT04259762 is a NA study that has completed, run by New Mexico Cancer Research Alliance. The registered enrollment target is 508 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04259762, a NA study, has completed, sponsored by New Mexico Cancer Research Alliance.

COMPLETED
Registry status
NA
Development phase
508 participants
Enrollment target

Study Summary

There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. In New Mexico (NM), AIs compared with other racial/ethnic populations are significantly less likely to adhere to recommended screening guidelines. The purpose of this trial is to develop and pilot test multilevel/multicomponent intervention strategies to enhance screening for breast, colorectal, and cervical cancers.

Interventions

  • OTHER Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions

Trial Details

FieldValue
Enrollment Target 508 participants
Start Date 2021-06-01
Est. Completion 2023-10-31
Phase NA

What the Registry Record Tells You About NCT04259762

The ClinicalTrials.gov registry entry for NCT04259762 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 508 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions is the first listed.

NCT04259762 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04259762 about?

NCT04259762 is a clinical study titled "Enhancing Cancer Prevention and Control Pathways-Native Health Initiative". There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. In New Mexico (NM), AIs compared with other racial/ethnic populations are significantly ...

What is the current status of trial NCT04259762?

This trial is currently completed. It is a NA study. The enrollment target is 508 participants. The study started on 2021-06-01. Estimated completion is 2023-10-31.

What interventions are being tested in trial NCT04259762?

The interventions under investigation include: Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions (OTHER).

Who is sponsoring clinical trial NCT04259762?

This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.